All sponsors

Shanghai Runshi Pharmaceutical Technology Co., Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-32
RECRUITING0
READOUTS ≤12 MONTHS4
Open Shanghai Runshi Pharmaceutical Technology Co., Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
DP303c
NCT06577376
P1/2Not yet recruitingLocalized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma; Expressing Human Epidermal Growth Factor Receptor-2 (HER-2)2522026-08-26
SYHA1813
NCT06682611
P1/2Not yet recruitingUnresectable Locally Advanced or Metastatic Solid Tumors3802026-11-13
simmitinib
NCT06656091
P3Not yet recruitingAdvanced Oesophageal Squamous Cell Carcinoma4502027-01-30
Simmitinib
NCT06132217
P1/2Not yet recruitingAdvanced Solid Tumor1682027-01-30
SYHA1813
NCT06739213
P2Not yet recruitingRecurrent or Progressive High Grade Meningioma562027-01-31
SYHA1813
NCT07613450
P3Not yet recruitingHigh Grade Meningioma1362029-07-31